Navigation Links
New AHIP Study in Health Affairs Challenges Previous Assumptions About Medigap's Impact on Medicare Costs
Date:3/12/2008

AHIP releases new study of Medigap market

WASHINGTON, March 12 /PRNewswire-USNewswire/ -- Groundbreaking research on Medicare supplemental insurance (Medigap) challenges previous assumptions about Medigap's impact on Medicare costs. The new study by America's Health Insurance Plans (AHIP) was published this week in the journal Health Affairs. AHIP also released a new analysis of the Medigap market which found that Medigap enrollment has remained constant in recent years, showing the value this option provides for Medicare beneficiaries.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGO )

"The new data provide a fresh perspective on Medigap coverage and its effect on health care costs in Medicare," said Karen Ignagni, President and CEO of AHIP.

Previous studies have asserted that Medigap policyholders incur as much as 25 percent more Medicare expenditures than beneficiaries with fee-for-service (FFS) Medicare only because Medigap generally provides coverage on a first-dollar basis, meaning it does not require any cost-sharing for beneficiaries.

The AHIP study shows that nearly half of this apparent increase in Medicare expenditures can be explained by controlling for the use of services received through the Veterans Administration (VA) or at military facilities. Thirteen percent of FFS-only beneficiaries relied on the VA or military facilities as their primary source of care, compared to just one percent of Medigap purchasers. These services are not billed to Medicare, causing Medicare costs for FFS-only beneficiaries to appear artificially low compared to beneficiaries with Medigap coverage.

Further, beneficiaries' health status may explain much of the remaining difference in health costs between these two groups. Previous studies argued that Medigap policyholders were healthier than FFS-only beneficiaries. These s
'/>"/>

SOURCE America's Health Insurance Plans
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. MHA to Release Findings of Independent Long Term Care Member Study
2. Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers
3. Radiologist Leora Lanzkowsky Study Suggests ...
4. Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association
5. Life Recovery Systems Study of Heart Attack With ThermoSuit(R) System
6. Gender bias may affect care of people with osteoarthritis, study finds
7. Lung damage in babies with congenital heart disease under study
8. The hand cant be fooled, study shows
9. Oregon study raises questions on synthetic progestins
10. PSA Test Losing Diagnostic Value, Study Says
11. Cerimon to Conduct a Proof of Concept Study for Basiliximab for Noninfectious Uveitis, a Potentially Sight-Threatening Inflammation of the Eye
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... a leading independent drug-formulation development and manufacturing ... hot-melt extrusion (HME) capacity with the addition ... , The 18mm Leistritz twin-screw mixer/extruder complements ... Baker Perkins extruder units, enhancing the company,s ... projects have been successfully advanced through the ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 (HealthDay News) -- ... common cause of snoring and daytime sleepiness, might also ... the condition -- the risk of developing high blood ... new cases of high blood pressure in two groups ... therapy, or CPAP, for either about four or 11 ...
(Date:5/22/2012)... itself with the daunting challenge of bringing mobility ... to a child in a developing country is ... engagement versus no societal engagement and individual freedom ... the Mercyhurst University Institute for Public Health, who ... to Guanajuato, Mexico, with a team of students, ...
(Date:5/22/2012)... Salamon HealthDay Reporter , , TUESDAY, May ... panel no longer recommends that men routinely undergo ... men should ask their doctors for the exam ... Urologists and cancer experts dismissed the idea ... of the PSA test will set a man,s ...
(Date:5/22/2012)... (May 22, 2012) Scientists at Virginia Commonwealth ... closer to developing a new therapy for acute ... agents obatoclax and sorafenib kill leukemia cells much ... are administered individually., Recently published in the journal ... Steven Grant, M.D., Shirley Carter Olsson and Sture ...
Breaking Medicine News(10 mins):Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:New initiative aims to increase mobility for disabled children worldwide 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 3Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3
... dialysis treatments, over 20% of 350,000 MHD patients die ... the// study, finds that this high mortality rate may ... Mass Combats Effects of Malnutrition From Treatment. Maintenance Hemodialysis ... paradox,” wherein obesity is associated with increased chance of ...
... a new study, septic shock—a dangerous, often deadly runaway ... research also suggests how a drug might// temper sepsis. ... been revealed in an experimental animal. ... Sabin Professor of Microbiology and Molecular Pathogenesis at NYU ...
... has been widely reported by women who complain of severe ... groin and genitalia after sexual// intercourse that has been now ... is triggered of by proteins present in semen. Thankfully doctors ... a way out for them according to the report made ...
... genes of progeny are dependant on a fairly simple ... potent enough to impact the genes of the future ... by expectant mice were seen to impact generation of ... National Academy of Sciences., ,To quote the researchers,” ...
... cancer deaths in the US. Smokers form the majority of ... one of the most deadly cancers, largely because it escapes ... five percent of pancreatic cancer patients survive the first five ... been reported that gum disease may increase the risk of ...
... of the physical and mental growth of children, Prime Minister ... preserve and promote" the health of the young. ,Inaugurating ... Singh stressed: "Health is also a fundamental human right. While ... is even more important to respect and uphold this right ...
Other Medicine News:Health News:New Study Finds On/Off Switch for Septic Shock 2Health News:See, men cause allergies in women after sex 2Health News:PM Stress the Need to Protect Health of Children 2
(Date:5/22/2012)... 22, 2012  Boehringer Ingelheim announced today ... the investigational compound tiotropium delivered once-daily via ... with symptomatic, moderate persistent asthma. The data ... of the American Thoracic Society (ATS 2012). ... Phase III trial program named UniTinA-asthma™ is ...
(Date:5/22/2012)... -- Accuray Incorporated (Nasdaq: ... today the signing of a multi-year master research ... Research Center (Deutsches Krebsforschungszentrum, DKFZ) a luminary ... DKFZ will collaborate on cutting-edge research in radiation ... care professionals with the most effective tools for ...
(Date:5/22/2012)... SANTA CLARA, Calif. and TEL AVIV, Israel, ... a technology-innovation leader focused on delivering ... imaging and ultrasound markets, today announced that ... Tritech Ltd.  Tritech, a leading Israeli stocking ... partner driving the success of Cephasonics, embedded-ultrasound ...
Breaking Medicine Technology:Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 2Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 3Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 4Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement 2Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement 3Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement 4Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel 2Bowel disease link to blood clots 66321 1Bowel disease link to blood clots 66321 2Bowel disease link to blood clots 66321 3Exploring the limits 3A Understanding the challenges facing Winter Olympic champions 66318 1Exploring the limits 3A Understanding the challenges facing Winter Olympic champions 66318 2KPA and TK Carsites offer HR OSHA and Internet Marketing Workshops at the NADA Convention and Expo 2010 66317 1KPA and TK Carsites offer HR OSHA and Internet Marketing Workshops at the NADA Convention and Expo 2010 66317 2
... * New data from 741-patient trial show those ... pressure,compared to ibuprofen[1] , * Many patients with ... in blood pressure can impact,cardiovascular risk[2],[3] , * ... currently under,review in US for use in osteoarthritis ...
... 2007 /PRNewswire/ -- VeroScience, LLC,a privately held ... that its late-breaking abstract has been,accepted as ... Sessions,of the American Diabetes Association in Chicago, ... (A Quick Release,Formulation of Bromocriptine Mesylate) Administration ...
Other Medicine Technology:Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 6VeroScience Late-Breaking Abstract on Cycloset (A Quick Release,Formulation of Bromocriptine Mesylate) Accepted for Poster,Presentation at American Diabetes Association 67th Scientific,Sessions 2
... (CRT) defibrillator system. It is the worlds ... status monitoring in the thoracic cavity, the ... This advance is expected to provide a ... thoracic fluid accumulation is a primary indicator ...
The most compact revolutionary innovation in hematology. 8 or 18 automated parameter hematology analyzer....
... a portable visual stimulation device, which can ... test system. Using LKCs exclusive Kurbisfeld technology, ... to meet the standards of the International ... (ISCEV). The stimulator provides for dim (-25 ...
... Mini-Ganzfeld Stimulator is an advanced, hand-held visual ... your existing LKC system or used as ... test systems. Using LKCs exclusive Kurbisfeld ... Ganzfeld to meet ISCEV (International Society for ...
Medicine Products: